 | • レポートコード：TPM-B04225 • 出版社/出版日：Transparency Market Research / 2018年3月 • レポート形態：英文、PDF、200ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、医薬品開発業務アウトソーシング（CRO）の世界市場について調べ、医薬品開発業務アウトソーシング（CRO）の世界規模、市場動向、市場環境、サービス別（臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他）分析、治療分野別（腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器） 分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・医薬品開発業務アウトソーシング（CRO）の世界市場動向 ・医薬品開発業務アウトソーシング（CRO）の世界市場環境 ・医薬品開発業務アウトソーシング（CRO）の世界市場規模 ・医薬品開発業務アウトソーシング（CRO）の世界市場規模：サービス別（臨床試験サービス、薬事サービス、臨床データ管理・バイオメトリクス、メディカルライティング、医薬品安全性監視、サイト管理プロトコル、その他） ・医薬品開発業務アウトソーシング（CRO）の世界市場規模：治療分野別（腫瘍・血液科、中枢神経系、心血管/代謝、呼吸器、感染病、免疫学、希少疾患、医療機器） ・医薬品開発業務アウトソーシング（CRO）の世界市場：地域別市場規模・分析 ・医薬品開発業務アウトソーシング（CRO）の北米市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）のアメリカ市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）のヨーロッパ市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）のアジア市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）の日本市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）の中国市場規模・予測 ・医薬品開発業務アウトソーシング（CRO）のインド市場規模・予測 ・競争状況・関連企業情報 |
Global Healthcare Contract Research Outsourcing Market: Overview
Now-a-days the drug development process is characterized by large clinical trials, rapid changes in trials protocols for efficient management of data generated and complex procedures, with the growing price of in-house research, the demand for contract research outsourcing is also increasing. These trends have formed pressure on healthcare companies to develop efficient drug development and product commercialization process. Along with the drug development efficiency, healthcare companies are looking to merge and simplify the supply chain, directing sourcing among a preferred number of multiple service providers. In response, large CROs are actively expanding their offerings beyond core clinical research services. Contract research organizations work closely with healthcare companies to conduct clinical research programs and support marketing activities for them. An increasing number of healthcare companies are outsourcing their clinical trials and other services to the contract research organizations.
This report on the healthcare contract research outsourcing market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. The research is a combination of primary and secondary research. Detailed qualitative analysis of factors responsible for driving and restraining market growth and opportunities has been provided in the market overview section. Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year.
Market related factors such as technological developments, product innovation, services offered, infrastructure facilities around the world, and historical year-on-year growth have been taken into consideration while estimating the market size. Growth rates for each segment within the healthcare contract research outsourcing market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, product development life cycle, and regulatory requirements. These factors would help the market players to take strategic decisions in order to strengthen their positions and expand their share in the global market.
Global Healthcare Contract Research Outsourcing Market: Key Segments
On the basis of services, the healthcare contract research outsourcing market is categorized into clinical trial services, regulatory services, clinical data management & biometrics, medical writing, pharmacovigilance, site management protocol and others. On the basis of therapeutic area the healthcare contract research outsourcing market is categorized into oncology/hematology, CNS, CV/metabolic, respiratory, infectious diseases, immunology, rare diseases, medical devices and others. In terms of end users, the healthcare contract research outsourcing market is segmented into hospitals, home care and clinics.
On the basis of geography, the healthcare contract research outsourcing market is segmented into North America, Europe, Asia Pacific and Rest of the world. North America comprises the U.S. and Canada. Europe comprises Germany, France, U.K., Spain, Italy and Rest of Europe. Asia-Pacific comprises China, India, Japan, Australia and New Zealand and Rest of Asia Pacific. The competition matrix section included in the report is likely to assist the existing players to increase their market shares and new companies to establish their presence in the healthcare contract research outsourcing market.
Companies Mentioned in Report
The report also profiles major players in the healthcare contract research outsourcing market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Syneos Health, PAREXEL International, ICON PLC, PRA Health Sciences, Inc., Charles River, Laboratory Corporation of America Holdings (Covance), IQVIA, Medpace, Pharmaceutical Product Development, LLC.
The Global Healthcare Contract Research Outsourcing market has been segmented as follows:
Global Healthcare Contract Research Outsourcings Market, by Service
Clinical Trial Service
Preclinical
Clinical
Regulatory Service
Clinical Data Management & Biometrics
Electronic data capture
Electronic Patient Recorded Outcomes
Others
Medical Writing
Pharmacovigilance
Site Management Protocol
Others
Global Healthcare Contract Research Outsourcings Market, by Therapeutic Area
Oncology/Hematology
CNS
CV/Metabolic
Respiratory
Infectious Diseases
Immunology
Rare Diseases
Medical Devices
Others
Global Healthcare Contract Research Outsourcings Market, by End User
Pharmaceutical Companies
Biotechnology Companies
Medical Device Companies
Academic Institutes & Government organizations
Global Healthcare Contract Research Outsourcings Market, by Geography
North America
U.S.
Canada
Europe
Germany
U.K.
France
Spain
Italy
Rest of Europe
Asia Pacific
Japan
China
India
Australia & New Zealand
Rest of Asia Pacific
Rest of the World
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Healthcare Contract Research Outsourcings Market
4. Market Overview
4.1. Introduction
4.1.1. Service Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, 2015–2025
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Porter’s Five Force Analysis
4.7. Regulatory Scenario
4.7.1. North America
4.7.2. Europe
4.7.3. Asia Pacific
4.8. Key Mergers and Acquisitions
4.9. Time and Cost Reduction in Clinical Trials
4.10. Market Outlook
5. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Service
5.1. Introduction & Definition
5.2. Key Findings
5.4. Market Value Forecast By Service , 2015–2025
5.4.1. Clinical Trial Service
5.4.1.1. Preclinical
5.4.1.2. Clinical
5.4.2. Regulatory Service
5.4.3. Clinical Data Management & Biometrics
5.4.3.1. Electronic data capture
5.4.3.2. Electronic Patient Recorded Outcomes
5.4.3.3. Others
5.4.4. Medical Writing
5.4.5. Pharmacovigilance
5.4.6. Site Management Protocol
5.4.7. Others
5.5. Market Attractiveness By Service
6. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Therapeutic Area
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.4. Market Value Forecast By Therapeutic Area , 2015–2025
6.4.1. Oncology/Hematology
6.4.2. CNS
6.4.3. CV/Metabolic
6.4.4. Respiratory
6.4.5. Infectious Diseases
6.4.6. Immunology
6.4.7. Rare Diseases
6.4.8. Medical Devices
6.4.9. Others
6.5. Market Attractiveness By Therapeutic Area
7. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By End User
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.4. Market Value Forecast By End User, 2015–2025
7.4.1. Pharmaceutical Companies
7.4.2. Biotechnology Companies
7.4.3. Medical Device Companies
7.4.4. Academic Institutes & Government organizations
7.5. Market Attractiveness By End User
8. Global Healthcare Contract Research Outsourcings Market Analysis and Forecasts, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Rest of the World
8.4. Market Attractiveness By Country/Region
9. North America Healthcare Contract Research Outsourcings Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Service , 2015–2025
9.2.1. Clinical Trial Service
9.2.1.1. Preclinical
9.2.1.2. Clinical
9.2.2. Regulatory Service
9.2.3. Clinical Data Management & Biometrics
9.2.3.1. Electronic data capture
9.2.3.2. Electronic Patient Recorded Outcomes
9.2.3.3. Others
9.2.4. Medical Writing
9.2.5. Pharmacovigilance
9.2.6. Site Management Protocol
9.2.7. Others
9.3. Market Value Forecast By Therapeutic Area , 2015–2025
9.3.1. Oncology/Hematology
9.3.2. CNS
9.3.3. CV/Metabolic
9.3.4. Respiratory
9.3.5. Infectious Diseases
9.3.6. Immunology
9.3.7. Rare Diseases
9.3.8. Medical Devices
9.3.9. Others
9.4. Market Value Forecast By End User, 2015–2025
9.4.1. Pharmaceutical Companies
9.4.2. Biotechnology Companies
9.4.3. Medical Device Companies
9.4.4. Academic Institutes & Government organizations
9.5. Market Value Forecast By Country , 2015–2025
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Service
9.6.2. By Therapeutic Area
9.6.3. By End User
9.6.4. By Country
10. Europe Healthcare Contract Research Outsourcings Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Service , 2015–2025
10.2.1. Clinical Trial Service
10.2.1.1. Preclinical
10.2.1.2. Clinical
10.2.2. Regulatory Service
10.2.3. Clinical Data Management & Biometrics
10.2.3.1. Electronic data capture
10.2.3.2. Electronic Patient Recorded Outcomes
10.2.3.3. Others
10.2.4. Medical Writing
10.2.5. Pharmacovigilance
10.2.6. Site Management Protocol
10.2.7. Others
10.3. Market Value Forecast By Therapeutic Area , 2015–2025
10.3.1. Oncology/Hematology
10.3.2. CNS
10.3.3. CV/Metabolic
10.3.4. Respiratory
10.3.5. Infectious Diseases
10.3.6. Immunology
10.3.7. Rare Diseases
10.3.8. Medical Devices
10.3.9. Others
10.4. Market Value Forecast By End User, 2015–2025
10.4.1. Pharmaceutical Companies
10.4.2. Biotechnology Companies
10.4.3. Medical Device Companies
10.4.4. Academic Institutes & Government organizations
10.5. Market Value Forecast By Country , 2015–2025
10.5.1. Germany
10.5.2. U.K.
10.5.3. France
10.5.4. Spain
10.5.5. Italy
10.5.6. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Service
10.6.2. By Therapeutic Area
10.6.3. By End User
10.6.4. By Country
11. Asia Pacific Healthcare Contract Research Outsourcings Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Service , 2015–2025
11.2.1. Clinical Trial Service
11.2.1.1. Preclinical
11.2.1.2. Clinical
11.2.2. Regulatory Service
11.2.3. Clinical Data Management & Biometrics
11.2.3.1. Electronic data capture
11.2.3.2. Electronic Patient Recorded Outcomes
11.2.3.3. Others
11.2.4. Medical Writing
11.2.5. Pharmacovigilance
11.2.6. Site Management Protocol
11.2.7. Others
11.3. Market Value Forecast By Therapeutic Area , 2015–2025
11.3.1. Oncology/Hematology
11.3.2. CNS
11.3.3. CV/Metabolic
11.3.4. Respiratory
11.3.5. Infectious Diseases
11.3.6. Immunology
11.3.7. Rare Diseases
11.3.8. Medical Devices
11.3.9. Others
11.4. Market Value Forecast By End User, 2015–2025
11.4.1. Pharmaceutical Companies
11.4.2. Biotechnology Companies
11.4.3. Medical Device Companies
11.4.4. Academic Institutes & Government organizations
11.5. Market Value Forecast By Country , 2015–2025
11.5.1. China
11.5.2. Japan
11.5.3. India
11.5.4. Australia & New Zealand
11.5.5. Rest of Asia Pacific
11.6. Market Attractiveness Analysis
11.6.1. By Service
11.6.2. By Therapeutic Area
11.6.3. By End User
11.6.4. By Country
12. Rest of the World Healthcare Contract Research Outsourcings Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Service , 2015–2025
12.2.1. Clinical Trial Service
12.2.1.1. Preclinical
12.2.1.2. Clinical
12.2.2. Regulatory Service
12.2.3. Clinical Data Management & Biometrics
12.2.3.1. Electronic data capture
12.2.3.2. Electronic Patient Recorded Outcomes
12.2.3.3. Others
12.2.4. Medical Writing
12.2.5. Pharmacovigilance
12.2.6. Site Management Protocol
12.2.7. Others
12.3. Market Value Forecast By Therapeutic Area , 2015–2025
12.3.1. Oncology/Hematology
12.3.2. CNS
12.3.3. CV/Metabolic
12.3.4. Respiratory
12.3.5. Infectious Diseases
12.3.6. Immunology
12.3.7. Rare Diseases
12.3.8. Medical Devices
12.3.9. Others
12.4. Market Value Forecast By End User, 2015–2025
12.4.1. Pharmaceutical Companies
12.4.2. Biotechnology Companies
12.4.3. Medical Device Companies
12.4.4. Academic Institutes & Government organizations
12.5. Market Value Forecast By Country , 2015–2025
12.6. Market Attractiveness Analysis
12.6.1. By Service
12.6.2. By Therapeutic Area
12.6.3. By End User
12.6.4. By Country
13. Competition Landscape
13.1. Market Player – Competition Matrix (By Tier and Size of companies)
13.2. Market Share Analysis By Company (2016)
13.3. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
13.3.1. Syneos Health
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Overview
13.3.1.3. Product Portfolio
13.3.1.4. SWOT Analysis
13.3.1.5. Strategic Overview
13.3.2. PAREXEL International
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Overview
13.3.2.3. Product Portfolio
13.3.2.4. SWOT Analysis
13.3.2.5. Strategic Overview
13.3.3. ICON PLC
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Overview
13.3.3.3. Product Portfolio
13.3.3.4. SWOT Analysis
13.3.3.5. Strategic Overview
13.3.4. PRA Health Sciences, Inc.
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Overview
13.3.4.3. Product Portfolio
13.3.4.4. SWOT Analysis
13.3.4.5. Strategic Overview
13.3.5. Charles River
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Overview
13.3.5.3. Product Portfolio
13.3.5.4. SWOT Analysis
13.3.5.5. Strategic Overview
13.3.6. Laboratory Corporation of America Holdings (Covance)
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Overview
13.3.6.3. Product Portfolio
13.3.6.4. SWOT Analysis
13.3.6.5. Strategic Overview
13.3.7. IQVIA
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Overview
13.3.7.3. Product Portfolio
13.3.7.4. SWOT Analysis
13.3.7.5. Strategic Overview
13.3.8. Medpace
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Overview
13.3.8.3. Product Portfolio
13.3.8.4. SWOT Analysis
13.3.8.5. Strategic Overview
13.3.9. Pharmaceutical Product Development, LLC.
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Overview
13.3.9.3. Product Portfolio
13.3.9.4. SWOT Analysis
13.3.9.5. Strategic Overview
Table 01: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 02: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 03: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2025
Table 04: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 05: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 06: Global Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Region, 2017–2025
Table 07: North America Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 08: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 09: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Service, 2017–2025
Table 10: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data Management & Biometrics, 2017–2025
Table 11: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 12: North America Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 13: Europe Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 14: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Services, 2017–2025
Table 15: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 16: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 17: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 18: Europe Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 19: Asia Pacific Healthcare Contract Research Outsourcing Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
Table 20: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 21: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 22: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 23: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 24: Asia Pacific Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025
Table 25: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Service, 2017–2025
Table 26: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Trial Services, 2017–2025
Table 27: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Clinical Data management & Biometrics, 2017–2025
Table 28: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by Therapeutic Area, 2017–2025
Table 29: Rest of World Healthcare Contract Research Outsourcing Market Size (US$ Mn) Forecast, by End-user, 2017–2025